ongoing

RADICAL PC – 2 is a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer.

The objectives of this trial are as follows:

Primary: To determine whether a systematic cardiovascular and lifestyle risk factor modification strategy reduces the risk of cardiovascular disease in men with a new diagnosis of prostate cancer.

Secondary: To determine whether a systematic cardiovascular and lifestyle risk modification strategy improves the cardiovascular risk profile; and to estimate the incremental cost-effectiveness ratio of a systematic cardiovascular and lifestyle risk factor modification strategy.

 

 

RADICAL-PC-2 update (download pdf)
Study Type

Interventional - Procedure

Study Design

Randomized controlled trial

NO. of Countries

10

NO. of Sites

59

NO. of Participants

4600

Study Period

2015 - 2025

Sponsor

PHRI

Canadian Cancer Society

Hamilton Health Sciences

Tolmar Pharmaceuticals Canada

Movember Foundation

Back To Top